TwinBeech Capital’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-39,000
Closed -$802K 626
2026
Q1
$802K Buy
+39,000
New +$879K 0.08% 296
2025
Q3
Sell
-56,470
Closed -$1.3M 778
2025
Q2
$1.3M Buy
+56,470
New +$1.31M 0.03% 380
2024
Q4
Sell
-163,203
Closed -$2.97M 867
2024
Q3
$2.97M Buy
+163,203
New +$3.11M 0.06% 353
2024
Q1
Sell
-33,978
Closed -$783K 795
2023
Q4
$783K Sell
33,978
-238,169
-88% -$5.33M 0.01% 513
2023
Q3
$6.26M Buy
+272,147
New +$6.92M 0.12% 224
2023
Q2
Sell
-43,179
Closed -$1.19M 808
2023
Q1
$1.19M Buy
43,179
+31,264
+262% +$825K 0.02% 436
2022
Q4
$271K Sell
11,915
-100,073
-89% -$2.79M 0.01% 639
2022
Q3
$3.81M Buy
+111,988
New +$4.14M 0.1% 237

Other funds holding PRVA

TwinBeech Capital's PRVA Position: Q2 2026 in Review

TwinBeech Capital sold out of Privia Health (PRVA) in Q2 2026, closing a stake of 39,000 shares — an estimated $802K sold.

TwinBeech Capital first reported a position in PRVA in Q3 2022 and held it in 8 quarters. The position peaked at $6.26M in Q3 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • TwinBeech Capital reported no remaining Privia Health position as of Q2 2026 after selling out during the quarter.
  • TwinBeech Capital sold 39,000 Privia Health shares in Q2 2026, an estimated $802K.
  • TwinBeech Capital first reported a position in Privia Health in Q3 2022 and held it in 8 quarters.
  • TwinBeech Capital's Privia Health position peaked at $6.26M in Q3 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.